Canonical ingredient
Benzeneacetamide, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-
ATENOLOL
99 linked products
Official identifiers
Names and synonyms
- Benzeneacetamide, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]- (en)
- atenolol (en)
- Aténolol (fr)
- Aténolol (fr-CA)
Source-scoped chemical properties
Every value keeps its own authority, licence and retrieval date. Conflicting values are not silently merged.
- canada dsl listing
- listed
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl bioaccumulative
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl inherently toxic aquatic
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets cepa categorization
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets environmental
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets human health
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl persistent
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl substance category
- Organics
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
Safety and technical documents
General references and manufacturer-specific SDS documents are kept separate.
No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.
End-to-end traceability
Only links supported by an identified source are published. Missing evidence remains explicitly unknown.
Evidence still missing
- Country or region of origin
- Raw-material producer
- Ingredient manufacturer
- Distributor
- Transformation steps
Documented origins
No origin has been proven yet by an explicit source.
Documented organizations
No organization has been proven yet by an explicit source.
Documented transformations
No transformation step has been proven yet by an explicit source.
Method: a company’s registration country is never used as evidence of a material’s origin.
Products containing this ingredient
AA-ATENIDONE
50 · MG
AA-ATENIDONE
100 · MG
ACT ATENOLOL
50 · MG
ACT ATENOLOL
100 · MG
AG-ATENOLOL
25 · MG
AG-ATENOLOL
50 · MG
AG-ATENOLOL
100 · MG
APO-ATENOL TAB 100MG
100 · MG
APO-ATENOL TAB 50MG
50 · MG
ATENOLOL
50 · MG
ATENOLOL
100 · MG
ATENOLOL
25 · MG
ATENOLOL
50 · MG
ATENOLOL
100 · MG
ATENOLOL
25 · MG
ATENOLOL
50 · MG
ATENOLOL
100 · MG
ATENOLOL
50 · MG
ATENOLOL
100 · MG
ATENOLOL
25 · MG
ATENOLOL - TAB 100MG
100 · MG
ATENOLOL - TAB 50MG
50 · MG
ATENOLOL TABLETS
25 · MG
ATENOLOL TABLETS
50 · MG
ATENOLOL TABLETS
100 · MG
ATENOLOL TABLETS 100MG
100 · MG
ATENOLOL TABLETS 50MG
50 · MG
ATENOLOL TABLETS, BP
50 · MG
ATENOLOL TABLETS, BP
100 · MG
AVA-ATENOLOL
25 · MG
BCI ATENOLOL
50 · MG
BCI ATENOLOL
100 · MG
BIO-ATENOLOL
50 · MG
BIO-ATENOLOL
100 · MG
BIO-ATENOLOL
25 · MG
DOM-ATENOLOL - 100MG
100 · MG
DOM-ATENOLOL - 50MG
50 · MG
FTP-ATENOLOL
50 · MG
FTP-ATENOLOL
100 · MG
IPG-ATENOLOL
25 · MG
IPG-ATENOLOL
50 · MG
IPG-ATENOLOL
100 · MG
JAMP ATENOLOL TABLETS
100 · MG
JAMP ATENOLOL TABLETS
50 · MG
JAMP ATENOLOL TABLETS
25 · MG
JAMP-ATENOLOL
25 · MG
JAMP-ATENOLOL
50 · MG
JAMP-ATENOLOL
100 · MG